IN2012DN04917A - - Google Patents

Download PDF

Info

Publication number
IN2012DN04917A
IN2012DN04917A IN4917DEN2012A IN2012DN04917A IN 2012DN04917 A IN2012DN04917 A IN 2012DN04917A IN 4917DEN2012 A IN4917DEN2012 A IN 4917DEN2012A IN 2012DN04917 A IN2012DN04917 A IN 2012DN04917A
Authority
IN
India
Prior art keywords
compounds
imidazo
methods
disclosed
pyridine
Prior art date
Application number
Inventor
Marvin J Miller
Garrett C Moraski
Lowell D Markley
George E Davis
Original Assignee
Univ Notre Dame Du Lac
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Notre Dame Du Lac, Dow Agrosciences Llc filed Critical Univ Notre Dame Du Lac
Publication of IN2012DN04917A publication Critical patent/IN2012DN04917A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pulmonology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Embodiments relate to the field of chemistry and biochemistry, and, more specifically, to imidazopyridine compounds, synthesis thereof, and methods of using same. Disclosed herein are various imidazo[1,2-a]pyridine compounds and methods of using the novel compounds to treat or prevent tuberculosis in a subject or to inhibit fungal growth on plant species. Other embodiments include methods of synthesizing imidazo[1,2-ijpyridine compounds, such as the disclosed imidazo[1,2-a]pyridine compounds.
IN4917DEN2012 2009-11-05 2010-11-05 IN2012DN04917A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25854909P 2009-11-05 2009-11-05
PCT/US2010/055728 WO2011057145A2 (en) 2009-11-05 2010-11-05 Imidazo[1,2-a] pyridine compounds, synthesis thereof, and methods of using same

Publications (1)

Publication Number Publication Date
IN2012DN04917A true IN2012DN04917A (en) 2015-09-25

Family

ID=43970798

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4917DEN2012 IN2012DN04917A (en) 2009-11-05 2010-11-05

Country Status (10)

Country Link
US (3) US9309238B2 (en)
EP (2) EP2496578A4 (en)
CN (3) CN106866667B (en)
BR (1) BR112012010752B1 (en)
HK (1) HK1248676A1 (en)
IL (1) IL219564A (en)
IN (1) IN2012DN04917A (en)
RU (1) RU2608611C2 (en)
WO (1) WO2011057145A2 (en)
ZA (1) ZA201204028B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106866667B (en) * 2009-11-05 2019-11-15 圣母大学 Imidazo [1,2-a] pyridine compounds and their and its synthesis and application method
EP2547678B1 (en) 2010-03-18 2016-03-16 Institut Pasteur Korea Anti-infective compounds
EP2671582B1 (en) 2011-02-01 2016-07-13 Kyowa Hakko Kirin Co., Ltd. Ring-fused heterocyclic derivative
US9029389B2 (en) 2011-04-21 2015-05-12 Institut Pasteur Korea Anti-inflammation compounds
CA2852615A1 (en) 2011-10-21 2013-04-25 Torrent Pharmaceuticals Limited Novel substituted imidazopyrimidines as gpbar1 receptor modulators
EP2881394B1 (en) 2012-07-31 2018-03-21 Kyowa Hakko Kirin Co., Ltd. Condensed ring heterocyclic compound
JP2016525562A (en) * 2013-08-02 2016-08-25 インスティチュート パスツール コリア Anti-infective compounds
WO2015143652A1 (en) * 2014-03-26 2015-10-01 Merck Sharp & Dohme Corp. TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
CN103965193B (en) * 2014-05-30 2016-04-06 浙江司太立制药股份有限公司 N-(benzene oxyalkyl) imidazo [1,2-a] pyridine-3-amides and preparation method thereof
CN104628721A (en) * 2015-01-22 2015-05-20 湖南华腾制药有限公司 Preparation method of imidazo [1, 2-a] pyridine derivative
BR112017028318B1 (en) 2015-07-02 2024-02-20 Janssen Sciences Ireland Uc ANTIBACTERIAL COMPOUND, ITS USE, PROCESS FOR ITS PREPARATION, PRODUCT CONTAINING IT, PHARMACEUTICAL COMPOSITION AND COMBINATION
KR20180053386A (en) 2015-09-17 2018-05-21 마빈 제이. 밀러 Useful benzylamine-containing heterocyclic compounds and compositions useful for mycobacterial infection
BR112018076126A2 (en) 2016-06-16 2019-03-26 Janssen Sciences Ireland Unlimited Company heterocyclic compounds as antibacterials
CA3025727A1 (en) 2016-06-16 2017-12-21 Janssen Sciences Ireland Unlimited Company Heterocyclic compounds as antibacterials
CN106588916A (en) * 2016-11-21 2017-04-26 浙江司太立制药股份有限公司 N-(phenoxyethyl) imidazo [1,2-a] pyridine-3-amide compound and preparation method thereof
EP3555098A1 (en) * 2016-12-16 2019-10-23 Bayer Aktiengesellschaft Mesoionic imidazopyridines for use as insecticides
JP7307682B2 (en) 2017-03-01 2023-07-12 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー Combination therapy
CN108159049B (en) * 2018-02-01 2021-01-05 中国科学院广州生物医药与健康研究院 New application of pyridine compound
WO2019175737A1 (en) * 2018-03-12 2019-09-19 University Of Notre Dame Du Lac Deuterated imidazopyridines
CN110759913B (en) * 2018-07-26 2022-01-28 南开大学 Indolylhydrazone derivatives, preparation method thereof and application thereof in plant virus prevention and control, sterilization and disinsection
CN113480541B (en) * 2019-03-07 2022-09-02 湖南化工研究院有限公司 Process for producing imidazopyridine compound and intermediate thereof
CN113874372A (en) * 2019-04-08 2021-12-31 Pi工业有限公司 Novel oxadiazole compounds for controlling or preventing phytopathogenic fungi
TW202124379A (en) 2019-09-10 2021-07-01 日商鹽野義製藥股份有限公司 Benzyl amine-containing 5,6-heteroaromatic compounds useful against mycobacterial infection
CN115073454B (en) * 2022-08-09 2024-03-08 贵州大学 Imidazo pyridine-2-oxazoline compound and preparation method and application thereof
WO2024161423A1 (en) * 2023-02-02 2024-08-08 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Small molecules for the treatment of mycobacterial diseases

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525602A1 (en) * 1982-04-21 1983-10-28 Synthelabo IMIDAZO (1,2-A) PYRIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
RO87859B (en) * 1982-12-27 1985-12-31 Eli Lilly And Company Process for preparing pyrazine and triazine imidazopyrimidin derivatives
FR2593818B1 (en) * 1986-02-05 1988-04-29 Synthelabo IMIDAZO (1,2-A) PYRIDINE ACYLAMINOMETHYL-3 DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DE4010797A1 (en) 1990-04-04 1991-10-10 Hoechst Ag SUBSTITUTED AZOLES, METHOD FOR THE PRODUCTION THEREOF, MEANS CONTAINING THEM AND THE USE THEREOF
DE4023215A1 (en) 1990-07-21 1992-01-23 Hoechst Ag New substd. azole derivs. angiotensin II antagonists - for treating hypertension, coronary insufficiency, myocardial infarct, coronary hypertrophy, arteriosclerosis etc.
JPH0539205A (en) 1990-12-21 1993-02-19 Takeda Chem Ind Ltd Agricultural/horticultural mixed composition
JP3026845B2 (en) 1991-02-20 2000-03-27 日清製粉株式会社 Piperidine derivative
US5464843A (en) 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
US5721273A (en) * 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
AU2223495A (en) 1994-04-15 1995-11-10 Yamanouchi Pharmaceutical Co., Ltd. Spiro compound and medicinal composition thereof
WO1996002542A1 (en) 1994-07-15 1996-02-01 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
US6323227B1 (en) 1996-01-02 2001-11-27 Aventis Pharmaceuticals Products Inc. Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
US6080767A (en) 1996-01-02 2000-06-27 Aventis Pharmaceuticals Products Inc. Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
JPH09249666A (en) 1996-01-12 1997-09-22 Takeda Chem Ind Ltd Production of tricyclic compound and its intermediate
SE9700661D0 (en) * 1997-02-25 1997-02-25 Astra Ab New compounds
AUPP278498A0 (en) * 1998-04-03 1998-04-30 Australian Nuclear Science & Technology Organisation Peripheral benzodiazepine receptor binding agents
EP1085846A2 (en) 1998-06-08 2001-03-28 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
GB2351081A (en) 1999-06-18 2000-12-20 Lilly Forschung Gmbh Pharmaceutically active imidazoline compounds and analogues thereof
US6632815B2 (en) 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
NZ517828A (en) 1999-09-17 2003-10-31 Millennium Pharm Inc Inhibitors having activity against mammalian factor Xa
US6403588B1 (en) * 2000-04-27 2002-06-11 Yamanouchi Pharmaceutical Co., Ltd. Imidazopyridine derivatives
ATE300540T1 (en) 2000-04-27 2005-08-15 Yamanouchi Pharma Co Ltd IMIDAZOPYRIDINE DERIVATIVES
US6552037B2 (en) * 2000-06-30 2003-04-22 Neurogen Corporation 2-Substituted imidazo[1,2-A]pyridine derivatives
GB0021670D0 (en) 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
DE10247269A1 (en) * 2002-10-10 2004-04-22 Grünenthal GmbH New C-(imidazo-(1,2-a)-pyridin-3-yl)-methylamines, are nitrogen monoxide synthase inhibitors useful e.g. for treating migraine, septic shock, neurodegenerative diseases, inflammatory pain or cancer
US20050008640A1 (en) 2003-04-23 2005-01-13 Wendy Waegell Method of treating transplant rejection
MXPA06007242A (en) 2003-12-23 2006-08-18 Pfizer Novel quinoline derivatives.
WO2005108399A1 (en) * 2004-05-10 2005-11-17 Banyu Pharmaceutical Co., Ltd. Imidazopyridine compound
US20060084806A1 (en) * 2004-07-21 2006-04-20 Ramasubramanian Sridharan Processes for the preparation of imidazo[1,2-a] pyridine derivatives
ATE390424T1 (en) * 2004-08-02 2008-04-15 Sanol Arznei Schwarz Gmbh CARBOXAMIDES OF INDOLICINE AND ITS AZA AND DIAZ DERIVATIVES
CA2585315A1 (en) * 2004-11-11 2006-05-18 Ferrer Internacional, S.A. Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto
WO2006067444A1 (en) * 2004-12-24 2006-06-29 Astrazeneca Ab Amide derivatives
WO2007015866A2 (en) 2005-07-20 2007-02-08 Kalypsys, Inc. Inhibitors of p38 kinase and methods of treating inflammatory disorders
WO2007136607A2 (en) 2006-05-18 2007-11-29 Merck & Co., Inc. Substituted esters as cannabinoid-1 receptor modulators
FR2903178B1 (en) 2006-07-03 2008-10-03 Rech S De L Ecole Nationale Su METHOD AND DEVICE FOR CLEANING SURFACES OF RUNNING WATER IN AN AIR / WATER THERMAL EXCHANGER
JP2010504957A (en) * 2006-09-29 2010-02-18 アクテリオン ファーマシューティカルズ リミテッド 3-Aza-bicyclo [3.1.0] hexane derivatives
MX2009003650A (en) * 2006-10-06 2009-04-22 Abbott Lab Novel imidazothiazoles and imidazoxazoles.
EP2134713A2 (en) * 2006-12-20 2009-12-23 Schering Corporation Novel jnk inhibitors
JP2010520293A (en) 2007-03-07 2010-06-10 アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド Metalloprotease inhibitors containing heterocyclic moieties
EP1980251A1 (en) * 2007-04-13 2008-10-15 Glaxo Group Limited Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
CL2008001631A1 (en) 2007-06-06 2009-01-02 Smithkline Beecham Corp Compounds derived from substituted heterocycles, with the presence of a phenoxy group, reverse transcriptase inhibitors; pharmaceutical composition; and use in the treatment of HIV viral infections.
JP5412429B2 (en) 2007-07-23 2014-02-12 クレストーン・インコーポレーテッド Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
WO2009086303A2 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
JP5774982B2 (en) * 2008-05-19 2015-09-09 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． Imidazo [1,2-a] pyridine compound
WO2009148961A2 (en) 2008-05-29 2009-12-10 Wisconsin Alumni Research Foundation Drugs to prevent hpv infection
CA2733247C (en) 2008-08-14 2018-04-03 Beta Pharma Canada Inc. Heterocyclic amide derivatives as ep4 receptor antagonists
US8198449B2 (en) * 2008-09-11 2012-06-12 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8293909B2 (en) 2008-09-11 2012-10-23 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
EP2376490B1 (en) * 2008-12-04 2013-01-23 Proximagen Limited Imidazopyridine compounds
WO2011050245A1 (en) 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
CN106866667B (en) * 2009-11-05 2019-11-15 圣母大学 Imidazo [1,2-a] pyridine compounds and their and its synthesis and application method
EP2547678B1 (en) 2010-03-18 2016-03-16 Institut Pasteur Korea Anti-infective compounds

Also Published As

Publication number Publication date
ZA201204028B (en) 2013-11-27
HK1248676A1 (en) 2018-10-19
EP2496578A4 (en) 2013-08-21
CN102762556B (en) 2017-04-26
US20180354944A1 (en) 2018-12-13
EP2496578A2 (en) 2012-09-12
WO2011057145A3 (en) 2011-09-09
US10913737B2 (en) 2021-02-09
US9908876B2 (en) 2018-03-06
US20160318925A1 (en) 2016-11-03
BR112012010752A2 (en) 2020-09-15
IL219564A (en) 2017-01-31
BR112012010752B1 (en) 2021-07-20
WO2011057145A2 (en) 2011-05-12
CN106866667A (en) 2017-06-20
EP3257854A1 (en) 2017-12-20
US9309238B2 (en) 2016-04-12
CN106866667B (en) 2019-11-15
CN110483499A (en) 2019-11-22
RU2608611C2 (en) 2017-01-23
US20120220457A1 (en) 2012-08-30
IL219564A0 (en) 2012-06-28
RU2012122653A (en) 2013-12-10
CN102762556A (en) 2012-10-31

Similar Documents

Publication Publication Date Title
IN2012DN04917A (en)
MX358682B (en) Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators.
MX2009010728A (en) Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors.
WO2012007345A3 (en) Substituted imidazo[1,2-a]pyrimidines and -pyridines
TNSN07323A1 (en) Imidazo (1, 2-a) pyridine compounds as vegf-r2 inhibitors
WO2006136357A3 (en) Crystalline modifications to pyraclostrobin
IL187586A0 (en) Method for producing dihydroquinazolines
EP2142544B8 (en) Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
MX2009007713A (en) Pyridazine derivatives, processes for their preparation and their use as fungicides.
MX2011008452A (en) Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer.
MX2009007436A (en) Spirocyclic tetronic acid derivatives.
TW200700064A (en) Novel compounds
HK1139948A1 (en) Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
WO2009114703A3 (en) Combination therapy for the treatment of cancer
WO2008140641A3 (en) Pure paliperidone and processes for preparing thereof
JO3611B1 (en) Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
TN2009000267A1 (en) 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
WO2007079119A3 (en) Process for manufacturing picolinate borinic esters
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
TW200745102A (en) Pyrido[2,3-d]pyrimidine derivatives, preparation thereof, therapeutic use thereof
MX2010002477A (en) Perharidines.
WO2009047634A3 (en) Aqueous formulations of acetaminophen for injection
NZ591837A (en) Amino acid derivative
WO2012033631A3 (en) Roseobacticides and uses thereof
WO2009081283A3 (en) Aqueous formulations of acetaminophen for injection